4.8 Article

Blockade of TLR3 protects mice from lethal radiation-induced gastrointestinal syndrome

Journal

NATURE COMMUNICATIONS
Volume 5, Issue -, Pages -

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/ncomms4492

Keywords

-

Funding

  1. Funding Program for World-leading Innovative R&D on Science and Technology (FIRST Program) of the Japanese Society for the Promotion of Science (JSPS)
  2. JSPS
  3. Special Coordination Funds of the Japanese Ministry of Education, Culture, Sports, Science and Technology
  4. Ministry of Health, Labour and Welfare in Japan
  5. Senri Life Science Foundation
  6. Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care
  7. Program for Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry
  8. Ministry of Education, Culture, Sports, Science and Technology of Japan for the Leading-edge Research Infrastructure Program
  9. Ministry of Health and Welfare of Japan
  10. Yakult Bio-Science Foundation

Ask authors/readers for more resources

High-dose ionizing radiation induces severe DNA damage in the epithelial stem cells in small intestinal crypts and causes gastrointestinal syndrome (GIS). Although the tumour suppressor p53 is a primary factor inducing death of crypt cells with DNA damage, its essential role in maintaining genome stability means inhibiting p53 to prevent GIS is not a viable strategy. Here we show that the innate immune receptor Toll-like receptor 3 (TLR3) is critical for the pathogenesis of GIS. Tlr3(-/-) mice show substantial resistance to GIS owing to significantly reduced radiation-induced crypt cell death. Despite showing reduced crypt cell death, p53-dependent crypt cell death is not impaired in Tlr3(-/-) mice. p53-dependent crypt cell death causes leakage of cellular RNA, which induces extensive cell death via TLR3. An inhibitor of TLR3-RNA binding ameliorates GIS by reducing crypt cell death. Thus, we propose blocking TLR3 activation as a novel approach to treat GIS.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available